Operational Experience of the Rospotrebnadzor Specialists during the Epidemic of Mpox in Eastern and Central Africa in 2024
Open Access
- 7 April 2025
- journal article
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 96-104
Abstract
The paper presents the results of work of the Russian and African experts on the study of the epidemiological and clinical features of mpox in some countries of Eastern (Republic of Rwanda, Uganda, Burundi) and Central (Republic of the Congo) Africa in the fall of 2024. An analysis of the epidemiological data obtained in the countries under consideration showed that in most cases, mpox was reported in patients of the pediatric age group. The disease was equally registered in both men and women. The clinical course of the disease was represented by mild and moderate severe forms. Severe cases of the disease have been reported only among patients with immunosuppression, untreated HIV infection or other somatic and/or infectious pathologies, as well as in children under 2 years of age. Pregnant patients also had a mild form of mpox. No deaths were reported. Monkey pox was accompanied with a simultaneous increase in cases of Varicella Zoster virus disease in the Republics of Burundi and Uganda. This circumstance often led to the registration of patients with that infection as suspected but unconfirmed cases of mpox. People with herpetic manifestations also fell into this category. Rospotrebnadzor specialists provided consulting and practical assistance to the African colleagues. Russian-made reagent kits for detecting DNA of the monkeypox virus using PCR were transferred to each country. Based on the results of the joint work, a number of relevant areas for studying the circulation of the causative agent of this infectious disease, the clinical and epidemiological features of it in the countries of East and Central Africa have been identified.Keywords
This publication has 16 references indexed in Scilit:
- Preliminary report on the molecular epidemiology of mpox, South Africa 2024bioRxiv, 2024
- The Resurgence of Mpox in AfricaJAMA, 2024
- First cases of mpox Clade I outside of Africa: genetic insights on its evolutionInfectious Diseases, 2024
- The worsening mpox outbreak in Africa: a call to actionThe Lancet Infectious Diseases, 2024
- Paediatric, maternal, and congenital mpox: a systematic review and meta-analysisThe Lancet Global Health, 2024
- Human Mpox in People Living with HIV: Epidemiologic and Clinical Perspectives from NigeriaAIDS Research and Human Retroviruses, 2023
- Mpox and HIV: a Narrative ReviewCurrent HIV/AIDS Reports, 2023
- Mpox respiratory transmission: the state of the evidenceThe Lancet Microbe, 2023
- Mpox in people with advanced HIV infection: a global case seriesThe Lancet, 2023
- Monkeypox and sex: Sexual orientations and encounters are key factors to considerHealth Science Reports, 2023